Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.

Vailati C, Mazzoleni G, Testoni PA, Passaretti S.

J Clin Gastroenterol. 2014 Aug;48(7):613-9. doi: 10.1097/MCG.0000000000000051.

PMID:
24326754
2.

Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, Galmiche JP.

Gut. 2012 Apr;61(4):501-6. doi: 10.1136/gutjnl-2011-300798.

PMID:
21997546
3.

Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?

de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.

Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221.

4.

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.

Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x.

PMID:
18684197
5.

Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.

Viazis N, Karamanolis GP, Anastasiou J, Keyoglou A, Vlachogiannakos J, Ladas SD, Karamanolis DG.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1450-5. doi: 10.1097/MEG.0b013e328365d2a8.

PMID:
24047861
6.

Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.

Kawamura O, Hosaka H, Shimoyama Y, Kawada A, Kuribayashi S, Kusano M, Yamada M.

Digestion. 2015;91(1):19-25. doi: 10.1159/000368766.

PMID:
25632912
7.

Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.

Roman S, Keefer L, Imam H, Korrapati P, Mogni B, Eident K, Friesen L, Kahrilas PJ, Martinovich Z, Pandolfino JE.

Neurogastroenterol Motil. 2015 Nov;27(11):1667-74. doi: 10.1111/nmo.12666.

8.

Factors associated with nonresponse to proton pump inhibitors therapy in patients referred for esophageal pH-impedance monitoring.

Garros A, Mion F, Marjoux S, Damon H, Roman S.

Dis Esophagus. 2016 Oct;29(7):787-793. doi: 10.1111/dote.12374.

PMID:
25951923
9.

Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.

Rohof WO, Bennink RJ, de Jonge H, Boeckxstaens GE.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1647-55. doi: 10.1016/j.cgh.2013.10.026.

PMID:
24184737
10.

Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.

Blondeau K, Boecxstaens V, Van Oudenhove L, Farré R, Boeckxstaens G, Tack J.

Neurogastroenterol Motil. 2011 Aug;23(8):724-e327. doi: 10.1111/j.1365-2982.2011.01720.x.

11.

Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.

Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R.

Aliment Pharmacol Ther. 2009 Sep 1;30(5):508-15. doi: 10.1111/j.1365-2036.2009.04063.x.

12.

Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.

Tokudome K, Funaki Y, Sasaki M, Izawa S, Tamura Y, Iida A, Ogasawara N, Konagaya T, Tokura Y, Kasugai K.

World J Gastroenterol. 2012 Nov 7;18(41):5940-7. doi: 10.3748/wjg.v18.i41.5940.

13.

The role of impedance monitoring in patients with extraesophageal symptoms.

Kavitt RT, Yuksel ES, Slaughter JC, Garrett CG, Hagaman D, Higginbotham T, Vaezi MF.

Laryngoscope. 2013 Oct;123(10):2463-8. doi: 10.1002/lary.23734.

PMID:
23857711
14.

The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.

Park EY, Choi MG, Baeg M, Lim CH, Kim J, Cho Y, Park J, Lee I, Kim S, Choi K.

Dig Dis Sci. 2013 Oct;58(10):2933-9. doi: 10.1007/s10620-013-2728-4.

PMID:
23765257
15.

Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.

Blonski W, Vela MF, Castell DO.

J Clin Gastroenterol. 2009 Oct;43(9):816-20. doi: 10.1097/MCG.0b013e318194592b.

PMID:
19398927
16.

Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.

Kohata Y, Fujiwara Y, Yamagami H, Tanigawa T, Shiba M, Watanabe K, Watanabe T, Tominaga K, Arakawa T.

J Gastroenterol Hepatol. 2015 Mar;30 Suppl 1:36-40. doi: 10.1111/jgh.12743.

PMID:
25827802
17.

Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.

Ribolsi M, Savarino E, De Bortoli N, Balestrieri P, Furnari M, Martinucci I, Casale M, Greco F, Salvinelli F, Savarino V, Marchi S, Cicala M.

Aliment Pharmacol Ther. 2014 Oct;40(8):966-73. doi: 10.1111/apt.12919.

18.

Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.

Becker V, Grotz S, Schlag C, Nennstiel S, Beitz A, Haller B, Schmid RM, Meining A, Bajbouj M.

World J Gastroenterol. 2014 Apr 14;20(14):4017-24. doi: 10.3748/wjg.v20.i14.4017.

19.

Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.

Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K, Ogasawara N, Sasaki M, Kaneko H, Kasugai K.

World J Gastroenterol. 2015 Apr 28;21(16):5009-16. doi: 10.3748/wjg.v21.i16.5009.

20.

Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.

Yamashita H, Ashida K, Fukuchi T, Nagatani Y, Koga H, Senda K, Eguchi T, Ubukata S, Kawaguchi S, Ueda A, Tanaka T, Ohashi R, Ito D.

J Smooth Muscle Res. 2012;48(5-6):125-35.

Supplemental Content

Support Center